Aderans hopefully soon
Collapse
X
-
Yup. For guys with thinning this has the potential to be far more effective than Fin. One patient had 80% increase... has Fin ever increased anyones hair density by 80%???Comment
-
Yeah are you joking? Fin without the consequences of hormone/chemical manipulation? That'd be a miracle really.Comment
-
Hi guys, I have a little bit of a good news
Aderans has updated their "Clinical Updates" section today by posting a video about what they can achieve! It clearly points out that they are able to regenerate new follicles to give you a full head of hair!!!
Check it out for yourself and let the discussions begin...LOL
http://www.aderansresearch.com/ari_whatwedo_moa.htmlComment
-
AFAIK, they can file for approval during Phase III.Comment
-
I DON'T get the mentality of some people: "Aderans will be useless if its just for maintenance", that's literally the most wrong-headed thing ever. That is the Holy Grail of treatments! And yes, perhaps a super-regrowth agent that turned a NW7 to a 2 or 1 with a short (or one-off) course of treatment would be better for more people, but one existing doesn't exclude the other. I think we all aknowledge that whatever next-gen treatment arrives first won't be perfect, unfortunately, but ANYTHING better/safer than fin/dut/minox would be an massive step forwards!Comment
-
Literally anything will be better. If we REALLY critically think about it, the available treatments right now are so primitive and outdated, not even funnyComment
-
I DON'T get the mentality of some people: "Aderans will be useless if its just for maintenance", that's literally the most wrong-headed thing ever. That is the Holy Grail of treatments! And yes, perhaps a super-regrowth agent that turned a NW7 to a 2 or 1 with a short (or one-off) course of treatment would be better for more people, but one existing doesn't exclude the other. I think we all aknowledge that whatever next-gen treatment arrives first won't be perfect, unfortunately, but ANYTHING better/safer than fin/dut/minox would be an massive step forwards!Comment
-
That's a waste of money for investors TBH. Can't believe anyone would invest in finasteride 2.0. For me it's all about results, not maintaining.I want regrowth, and i'm sure that is what the majority of people want. So if Aderans is all about maintaining, then it's a failure IMO. We're tired of "maintaining".Comment
-
And if they were able to duplicate that 80% hair regrowth statistic, then I would just literally cry with joy.Comment
-
I kind of agree in that I don't think Aderans would recoup all of their costs if they just came out with a version of finasteride without the side effects. I think their primary goal was regrowth and not simply halting hair loss, but people on here are saying that now their goal is simply hair maintenance. Can anyone provide any evidence of this?
Furthermore, I think the best evidence we have is that in all their Ji Gami trials, subjects are considered as "RESPONDERS" if they achieve the same results as ppl on Propecia. They have highlighted this fact over and over again in all of their presentations!
And as we know, Propecia is NOT exactly a re-growth therapy per se but rather a maintenance therapy!
All in all though, if we finally get lucky and Aderans decides to proceed to Phase 3 then we will be in a much better position then we are today!
Waiting for any news is really draining though...2013 was meant to be full of hairloss newsComment
-
I kind of agree in that I don't think Aderans would recoup all of their costs if they just came out with a version of finasteride without the side effects. I think their primary goal was regrowth and not simply halting hair loss, but people on here are saying that now their goal is simply hair maintenance. Can anyone provide any evidence of this?Comment
-
If there are no formal phase III announcements by June of this year, i would be inclined to think that Aderans may close the book on the cellular based therapeutics for hairloss. Based on their most recent presentation, only 4 out of 10 people even responded at all to jigami. That means for the large majority of people who take this treatment, there wont even be a chance for any regrowth at all. That's going to seriously impact their return on investment and make marketing their treatment difficult.
Perhaps they'll get a better responder rate when they look at all their phase II data. But if they don't, i'm not convinced they can justify going ahead with a costly phase III.
Lets keep our fingers crossed and hope for the best. Right now, i'm betting on Histogen. But, lets see some data...feel like we've been in a data drought since replicel sh*t the bed.Comment
Comment